CVS-Caremark will shell out $650,000 to help New Jersey authorities establish an education and enforcement campaign on prescription drug safety and abuse, a payment that settles charges that the drug store chain co-mingled prescription pills in several of its pharmacies in the state.
The payment will help fund a public education campaign that will remind consumers to check their medication, learn about it through available resources and, whenever they have questions about the medication, to ask their pharmacist or physician. It will also address the dangers of prescription drug abuse, according to this report.
This isn’t the first tangle CVS has had with officials over prescription drugs. Last year, the DEA revoked the controlled substances licenses for two CVS pharmacies in Sanford, Fla. after accusing them of dispensing excessive amounts of oxycodone.